Greg Wells
2200 Pennsylvania Avenue NW
Suite 500 West
Washington, D.C. 20037
Greg represents companies in high-stakes private antitrust litigation and government investigations in the U.S. and around the world, with a particular focus on single-firm conduct issues. He also advises on cutting-edge state and federal antitrust and distribution and compliance issues, including licensing and use of intellectual property. He also has extensive experience opposing class certification in private antitrust and consumer protection class actions, including working extensively with economic and industry experts.
In addition to his antitrust counseling, government investigations, and litigation practice, Greg frequently provides pro bono legal representation, including serving as lead trial counsel in litigation against the United States arising out of the loss of much of an artist’s professional portfolio while on loan to the government as part of a cultural exchange program.
Greg is active in the American Bar Association Section of Antitrust Law. He served as vice chair of the Books and Treatises Committee, editorial board member for the Annual Review of Antitrust Law Developments, project chair for the Antitrust Class Actions Handbook, and as the editor and a principal author for the class certification chapter in the Indirect Purchaser Litigation Handbook.
Experience Highlights
Represented U.S. technology company in competition investigations and litigation in the U.S., Europe, Russia, Korea, and Taiwan; team persuaded the Korean Fair Trade Commission and Taiwan Fair Trade Commission to dismiss complaints and close investigations
(N.D. Cal.) — Represented patent holder and chip manufacturer for advanced cellular technologies in competition investigations and litigation in the U.S., Japan, and Taiwan regarding FRAND licensing and related issues
(S.D.N.Y.) — Represented financial services firm in antitrust class action alleging manipulation of ISDAFIX financial benchmark
(D. Del. and California) — Represented microprocessor manufacturer in federal and state monopolization class actions, alleging exclusive dealing through loyalty discounts and other non-price conduct; team successfully opposed class certification in both federal and state court
(N.D. Cal) — Represented office equipment supplier in Kodak-type antitrust and RICO actions alleging monopolization of single-product aftermarket through fraudulent marketing practices
(D. Conn.) — Obtained voluntary dismissal of federal data privacy class action against office equipment supplier related to data retention practices for used equipment
(U.S. Court of Federal Claims) — Lead trial lawyer in government contracts and copyright litigation arising out of destruction of client’s property while part of a cultural exchange
Credentials
- Georgetown University Law Center, cum laude, J.D., 2000
- University of California, Davis, B.A., with honors, 1997
- Judicial Intern, Chambers of Judge Marian Blank Horn, U.S. Court of Federal Claims
- Recognized, U.S. News & World Report and Best Lawyers 2017 Practice Group of the Year for Antitrust Law, Law360 2018 Practice Group of the Year for Antitrust
- Nominee: Concurrences’ Antitrust Writing Award (2015)
- Legal 500 U.S., Antitrust: Cartel, Civil Litigation/Class Action – Defense, and Merger Control, 2019
- Member: American Bar Association, Section of Antitrust Law
- Former Vice Chair: ABA Section of Antitrust Law, Books and Treatises Committee
- Assistant Editor, American Criminal Law Review
- California, District of Columbia, U.S. Court of Appeals for the Second Circuit, U.S. Court of Federal Claims, U.S. District Court for the Northern District of California
- InsightJanuary 11, 2024
- InsightOctober 5, 2023
- InsightSeptember 28, 2023
- InsightJuly 17, 2023
- InsightJuly 17, 2023
- InsightFebruary 23, 2023
V&E Antitrust Update
- InsightJanuary 18, 2022
- “Elephants in Mouseholes: Lessons for Joint Ventures from the Intellectual Property World,” Antitrust Magazine, Vol. 30, No. 3, Summer 2016
- Emerging Competition Issues Involving Follow-On Biologics, Antitrust Magazine, Vol. 29, No. 1, 2014
- REMS: The Next Pharmaceutical Enforcement Priority?, Antitrust Magazine, Vol. 28, No. 2, 2014
- The “Litigation Mulligan” in the 2010 Merger Guidelines: Better Economics but Not (Necessarily) More Clarity Before the Agencies and the Courts, CPI Antitrust Journal, October 2010
- Raising Rivals’ Costs: The Problem of Remedies, George Mason Law Review, Vol. 12:2, 2003